Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

QurAlis

QurAlis
2016 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Seed LATEST DEAL TYPE
$5.5M LATEST DEAL AMOUNT
6 INVESTORS
Description

Operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS .

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Therapeutic Devices
Primary Office
  • 700 Main Street, North
  • Cambridge, MA 02139
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore QurAlis’s full profile, request a free trial.

QurAlis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 19-Nov-2018 $5.5M 00.00 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

QurAlis Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroNascent Venture Capital-Backed Clarksville, MD 0 00.000 0000000000 0 00.000
000000 000000 Formerly VC-backed Laval, Canada 00 000.00 000000000 000.00
000000000 00000000 Venture Capital-Backed Cambridge, MA 00 000.00 0&0
000000 00000000000 Venture Capital-Backed Cambridge, MA 0 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed South San Francisco, CA 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

QurAlis Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
BioInnovation Capital Venture Capital Minority 000 0000 000000 0
MP Healthcare Venture Management Corporate Venture Capital Minority 000 0000 000000 0
Viva biotech VC-Backed Company Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

QurAlis Executive Team (5)

Name Title Board
Seat
Contact
Info
Kasper Roet Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Daniel Elbaum Ph.D Chief Scientific Officer
Kevin Eggan Ph.D Co-Founder
Jonathan Fleming Co-Founder & Executive Chairman
Clifford Woolf Ph.D Co-Founder

QurAlis Board Members (5)

Name Representing Role Since Contact
Info
David Margulies MD Self Board Member 000 0000
Jeffrey Moore Ph.D MP Healthcare Venture Management Board Member 000 0000
Johannes Fruehauf Ph.D BioInnovation Capital Board Member 000 0000
Jonathan Fleming Self Co-Founder & Executive Chairman 000 0000
Kasper Roet Ph.D QurAlis Co-Founder, Chief Executive Officer, President & Board Member 000 0000